Investor Presentaiton
Historical and Forecasted Global Market Size of Cell and Gene Therapy
CDMO, 2015-2032E
Global cell and gene therapy CDMO services market increases from USD0.8 billion in 2015 to USD3.9 billion in 2022
with a CAGR of 24.6%. The market will continue to grow to USD11.6 billion by 2027 with a CAGR of 24.4% from 2022 to
2027. It's expected to reach USD42.5 billion in 2032 with a CAGR of 29.7% from 2027 to 2032.
Historical and Forecasted Global Market Size of Cell and Gene Therapy CMO/CDMO, 2015-2032E
ROW
China
Period
US
EU5
Total
based
2015-2022 27.1% 23.3% 25.9% 18.2% 24.6%
2022-2027E 25.5% 23.2% 24.7% 21.8% 24.4%
2027E-2032E 29.0% 28.9% 37.1% 29.0% 29.7%
42.5
33.2
25.9
20.0
15.3
Billion USD
11.6
8.8
6.8
3.4
3.9
4.6
5.5
0.8
1.0
1.2
1.5
1.9
2.3
2015
2016
2017
2018
2019 2020
2021 2022
2023E 2024E 2025E 2026E 2027E 2028E 2029E 2030E 2031E 2032E
■ US
EU5
China based
ROW
Note: Cell and Gene Therapies include mRNA and its plasmid, but oligonucleotides or Gene detection are not included.
Source: Frost & Sullivan analysis
药明康德
? Wuxi AppTecView entire presentation